Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006470 · ClinicalTrials.gov registry record · Phase 2
Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00006470 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group.
The verdict
NCT00006470, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining these two treatments may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining vaccine therapy with radiation therapy in treating patients who have stage II or stage IIIA non-small cell lung cancer that has been completely removed in surgery.
Interventions
- RADIATION radiation therapy
- BIOLOGICAL monoclonal antibody 11D10 anti-idiotype vaccine
- BIOLOGICAL monoclonal antibody 3H1 anti-idiotype vaccine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006470
The ClinicalTrials.gov registry entry for NCT00006470 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which radiation therapy is the first listed.
NCT00006470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006470 about?
NCT00006470 is a clinical study titled "Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery". RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining these two treatments may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining vaccine therapy with radiati...
What is the current status of trial NCT00006470?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-03.
What interventions are being tested in trial NCT00006470?
The interventions under investigation include: radiation therapy (RADIATION), monoclonal antibody 11D10 anti-idiotype vaccine (BIOLOGICAL), monoclonal antibody 3H1 anti-idiotype vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00006470?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.